Incidental Mutation 'IGL02089:Lypla2'
ID 279359
Institutional Source Australian Phenomics Network (link to record)
Gene Symbol Lypla2
Ensembl Gene ENSMUSG00000028670
Gene Name lysophospholipase 2
Synonyms LysoII, lysophospholipase II
Accession Numbers
Essential gene? Probably non essential (E-score: 0.176) question?
Stock # IGL02089
Quality Score
Status
Chromosome 4
Chromosomal Location 135695535-135699937 bp(-) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) C to T at 135696932 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Isoleucine at position 117 (V117I)
Ref Sequence ENSEMBL: ENSMUSP00000101478 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000067567] [ENSMUST00000102540] [ENSMUST00000102541] [ENSMUST00000105852] [ENSMUST00000143304] [ENSMUST00000149636]
AlphaFold Q9WTL7
Predicted Effect probably benign
Transcript: ENSMUST00000067567
AA Change: V117I

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000064204
Gene: ENSMUSG00000028670
AA Change: V117I

DomainStartEndE-ValueType
Pfam:Abhydrolase_2 11 228 4.8e-89 PFAM
Pfam:Abhydrolase_5 26 211 2.6e-12 PFAM
Pfam:Abhydrolase_6 27 167 6.5e-13 PFAM
Pfam:Abhydrolase_3 80 170 3.1e-7 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000102540
SMART Domains Protein: ENSMUSP00000099599
Gene: ENSMUSG00000028671

DomainStartEndE-ValueType
Pfam:RmlD_sub_bind 1 194 1.9e-14 PFAM
Pfam:adh_short 2 142 4.4e-14 PFAM
Pfam:KR 3 146 3.6e-10 PFAM
Pfam:Polysacc_synt_2 4 193 8.8e-14 PFAM
Pfam:NAD_binding_10 4 213 1.1e-11 PFAM
Pfam:Epimerase 4 269 3.7e-55 PFAM
Pfam:3Beta_HSD 5 171 3.6e-18 PFAM
Pfam:NAD_binding_4 6 230 1.6e-11 PFAM
Pfam:Epimerase_Csub 282 343 3.1e-33 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000102541
SMART Domains Protein: ENSMUSP00000099600
Gene: ENSMUSG00000028671

DomainStartEndE-ValueType
Pfam:RmlD_sub_bind 1 184 3.5e-14 PFAM
Pfam:KR 3 144 9.5e-10 PFAM
Pfam:Polysacc_synt_2 4 193 7.6e-14 PFAM
Pfam:Epimerase 4 269 3.5e-54 PFAM
Pfam:3Beta_HSD 5 172 2e-18 PFAM
Pfam:GDP_Man_Dehyd 5 332 2.5e-60 PFAM
Pfam:NAD_binding_4 62 233 2.5e-7 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000105852
AA Change: V117I

PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
SMART Domains Protein: ENSMUSP00000101478
Gene: ENSMUSG00000028670
AA Change: V117I

DomainStartEndE-ValueType
Pfam:Abhydrolase_2 11 228 2.3e-92 PFAM
Pfam:Abhydrolase_5 26 211 3.1e-12 PFAM
Pfam:Abhydrolase_6 27 225 1.2e-7 PFAM
Pfam:DLH 85 223 4.8e-8 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000128929
Predicted Effect probably benign
Transcript: ENSMUST00000143304
SMART Domains Protein: ENSMUSP00000119514
Gene: ENSMUSG00000028671

DomainStartEndE-ValueType
Pfam:Epimerase 4 55 1.2e-8 PFAM
Predicted Effect noncoding transcript
Transcript: ENSMUST00000145350
Predicted Effect noncoding transcript
Transcript: ENSMUST00000153542
Predicted Effect noncoding transcript
Transcript: ENSMUST00000156948
Predicted Effect noncoding transcript
Transcript: ENSMUST00000150430
Predicted Effect noncoding transcript
Transcript: ENSMUST00000150978
Predicted Effect probably benign
Transcript: ENSMUST00000149636
SMART Domains Protein: ENSMUSP00000117923
Gene: ENSMUSG00000028671

DomainStartEndE-ValueType
Pfam:Epimerase 4 58 1.3e-8 PFAM
Coding Region Coverage
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] Lysophospholipases are enzymes that act on biological membranes to regulate the multifunctional lysophospholipids. There are alternatively spliced transcript variants described for this gene but the full length nature is not known yet. [provided by RefSeq, Jul 2008]
Allele List at MGI
Other mutations in this stock
Total: 52 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
9330160F10Rik C T 11: 68,951,013 (GRCm39) silent Het
Adck1 G T 12: 88,413,480 (GRCm39) V271F probably damaging Het
Aggf1 T C 13: 95,507,437 (GRCm39) D116G probably benign Het
Anapc1 A T 2: 128,505,853 (GRCm39) V661E probably damaging Het
Apoa5 T C 9: 46,180,437 (GRCm39) probably null Het
Atp8a2 C T 14: 60,264,369 (GRCm39) probably null Het
Bnipl A T 3: 95,157,577 (GRCm39) probably benign Het
Cbs T G 17: 31,834,519 (GRCm39) D490A probably benign Het
Chrdl1 G T X: 142,086,510 (GRCm39) H199N possibly damaging Het
Dcaf1 C T 9: 106,740,310 (GRCm39) T1232I probably benign Het
Ddx19b T C 8: 111,735,477 (GRCm39) probably benign Het
Ephb4 A G 5: 137,369,024 (GRCm39) K805E probably damaging Het
Ergic3 A G 2: 155,852,395 (GRCm39) N135D probably benign Het
Fbxw18 C T 9: 109,530,390 (GRCm39) V74I probably benign Het
Fmo4 G T 1: 162,626,649 (GRCm39) T299N probably benign Het
Gmeb1 T C 4: 131,953,147 (GRCm39) K540E probably damaging Het
H60c T A 10: 3,209,826 (GRCm39) S154C possibly damaging Het
Herc1 T C 9: 66,388,151 (GRCm39) L3812S probably damaging Het
Hipk3 T C 2: 104,261,724 (GRCm39) D937G probably damaging Het
Ift122 A G 6: 115,902,398 (GRCm39) D1079G probably benign Het
Il6st T C 13: 112,631,774 (GRCm39) W438R probably benign Het
Mapk8ip1 T C 2: 92,216,220 (GRCm39) Y516C probably damaging Het
Mmp24 G A 2: 155,654,213 (GRCm39) G397D probably damaging Het
Muc4 G A 16: 32,570,131 (GRCm39) S397N possibly damaging Het
Muc5b T G 7: 141,416,987 (GRCm39) V3311G probably benign Het
Naca A G 10: 127,872,358 (GRCm39) probably benign Het
Nrxn1 A G 17: 91,395,829 (GRCm39) V109A probably benign Het
Nup210 T G 6: 91,053,680 (GRCm39) D279A probably benign Het
Or10g6 A T 9: 39,934,066 (GRCm39) I126F probably damaging Het
Or8h7 A G 2: 86,721,460 (GRCm39) S20P possibly damaging Het
Pappa T A 4: 65,074,361 (GRCm39) V305E possibly damaging Het
Pcdh19 A T X: 132,489,245 (GRCm39) M977K probably benign Het
Pdzph1 T A 17: 59,274,334 (GRCm39) I837F possibly damaging Het
Phip A T 9: 82,753,372 (GRCm39) L1791M probably damaging Het
Pkdrej C T 15: 85,700,489 (GRCm39) V1816I possibly damaging Het
Ptprz1 G A 6: 23,033,447 (GRCm39) V1063M probably damaging Het
Qprt A T 7: 126,707,528 (GRCm39) M220K probably damaging Het
R3hcc1 T C 14: 69,937,475 (GRCm39) K391E possibly damaging Het
Rbbp7 C A X: 161,554,052 (GRCm39) P162Q probably benign Het
Rev3l A T 10: 39,701,095 (GRCm39) N1864I probably damaging Het
Rims1 A G 1: 22,669,556 (GRCm39) I84T possibly damaging Het
Rnase2b A T 14: 51,400,240 (GRCm39) K107I probably benign Het
Sbf1 C A 15: 89,186,708 (GRCm39) E864* probably null Het
Strip2 G A 6: 29,917,179 (GRCm39) probably benign Het
Stx4a T C 7: 127,447,570 (GRCm39) I238T probably damaging Het
Tbc1d2b C T 9: 90,104,412 (GRCm39) V577I possibly damaging Het
Tex38 T C 4: 115,637,591 (GRCm39) T71A possibly damaging Het
Usp38 T C 8: 81,712,343 (GRCm39) E564G possibly damaging Het
Vmn2r72 A T 7: 85,387,374 (GRCm39) V730E probably benign Het
Wwp2 T A 8: 108,280,689 (GRCm39) L644Q probably damaging Het
Zfp267 T C 3: 36,218,877 (GRCm39) F300S possibly damaging Het
Zpld1 A G 16: 55,071,974 (GRCm39) I95T probably benign Het
Other mutations in Lypla2
AlleleSourceChrCoordTypePredicted EffectPPH Score
R1353:Lypla2 UTSW 4 135,697,778 (GRCm39) missense probably null 0.15
R2171:Lypla2 UTSW 4 135,697,915 (GRCm39) splice site probably null
R4177:Lypla2 UTSW 4 135,696,403 (GRCm39) unclassified probably benign
R6692:Lypla2 UTSW 4 135,698,173 (GRCm39) missense probably benign 0.00
R8074:Lypla2 UTSW 4 135,697,112 (GRCm39) critical splice donor site probably null
X0024:Lypla2 UTSW 4 135,696,486 (GRCm39) missense probably damaging 1.00
Posted On 2015-04-16